We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Surmasis Reprimanded for Laboratory Records, Equipment Inspections
Surmasis Reprimanded for Laboratory Records, Equipment Inspections
The FDA hit Surmasis Pharmaceutical of Des Moines, Iowa with a Form 483 after a February inspection revealed problems with laboratory records, computer systems and equipment inspections.